Merck & Co., Inc. (NYSE:MRK) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. FDA Fast-Tracks Two Merck (MRK) Drugs With Blockbuster Potential On December 17, the US Food and Drug Administration moved to fast-track reviews of two experimental Merck & Co., Inc. (NYSE:MRK) drugs with multibillion-dollar potential, according to internal documents seen by Reuters. Merck’s cholesterol pill enlicitide decanoate and its cancer therapy sacituzumab tirumotecan, also known as sac-TMT, were sel ...